Value in Health, 1098-3015

Journal

Publications

  1. 2020
  2. Accepted/In press
  3. 2019
  4. Published
  5. Published
  6. 2018
  7. Published
  8. Published

    Core Items for a Standardized Resource Use Measure (ISRUM): Expert Delphi Consensus Survey

    Ruth Riley, Jun 2018, In : Value in Health. 21, 6, p. 640-649

    Research output: Contribution to journalArticle

  9. 2017
  10. Published
  11. E-pub ahead of print
  12. E-pub ahead of print
  13. E-pub ahead of print
  14. Published
  15. 2016
  16. E-pub ahead of print
  17. Published
  18. 2015
  19. Published

    Health utility values associated with surgical site infection: a systematic review

    Grace Turner & Melanie Calvert, Dec 2015, In : Value in Health. 18, 8, p. 1126-37 12 p.

    Research output: Contribution to journalArticle

  20. Published

    A systematic review of research guidelines in Decision-Analytic Modelling

    Cristina Penaloza, Pelham Barton, Sue Jowett & Andrew Sutton, Jun 2015, In : Value in Health. 18, 4, p. 512-29 18 p.

    Research output: Contribution to journalArticle

  21. 2014
  22. Published
  23. Published

    Trends In Clinical Drug Development Timeframes, 1981-2013 - An Example From Virology

    Andrew Stevens, Nov 2014, In : Value in Health. 17, 7, p. A408

    Research output: Contribution to journalArticle

  24. Published
  25. Published
  26. 2013
  27. Published

    Development of a database of instruments for resource-use measurement: purpose, feasibility, and design

    Jo Coast, 2013, In : Value in Health. 15, 5, p. 650-5 6 p.

    Research output: Contribution to journalArticle

  28. 2012
  29. Published
  30. Published
  31. 2011
  32. Published
  33. Published
  34. Published
  35. Published
  36. 2010
  37. Published

    Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty

    Alan Girling & Richard Lilford, 1 Aug 2010, In : Value in Health. 13, 5, p. 585-591 7 p.

    Research output: Contribution to journalArticle

  38. 2009
  39. Published

    Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma

    Zulian Liu, 7 Oct 2009, In : Value in Health. 13, 1, p. 55-60 6 p.

    Research output: Contribution to journalArticle

  40. Published

    Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma

    Zulian Liu, 7 Oct 2009, In : Value in Health. 13, 1, p. 61-8 8 p.

    Research output: Contribution to journalArticle

  41. 2008
  42. Published

    A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics

    Sue Jowett, Stirling Bryan, 1 Mar 2008, In : Value in Health. 11, 2, p. 207-212 6 p.

    Research output: Contribution to journalArticle

  43. 2003
  44. Published
  45. 2002
  46. Published